Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Epigenetic regulation of microRNA expression in renal cell carcinoma.

Schiffgen M, Schmidt DH, von Rücker A, Müller SC, Ellinger J.

Biochem Biophys Res Commun. 2013 Jun 21;436(1):79-84. doi: 10.1016/j.bbrc.2013.05.061. Epub 2013 May 22.

PMID:
23707942
2.
3.
4.

Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.

Deng G, Kakar S, Okudiara K, Choi E, Sleisenger MH, Kim YS.

Clin Cancer Res. 2009 Mar 1;15(5):1519-26. doi: 10.1158/1078-0432.CCR-08-1778. Epub 2009 Feb 17.

5.

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.

Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R.

Int J Cancer. 2008 Aug 1;123(3):535-42. doi: 10.1002/ijc.23514.

6.

Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.

Liu Y, Hong Y, Zhao Y, Ismail TM, Wong Y, Eu KW.

Cancer Invest. 2008 Jul;26(6):575-82. doi: 10.1080/07357900701837168.

PMID:
18584348
7.

Demethylation of miR-10b plays a suppressive role in ccRCC cells.

He C, Zhao X, Jiang H, Zhong Z, Xu R.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10595-604. eCollection 2015.

8.

Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.

Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D.

J Pathol. 2007 Jun;212(2):134-42.

PMID:
17471463
9.
10.

Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Res. 2006 May 15;66(10):5021-8.

11.

Heparanase expression is associated with histone modifications in glioblastoma.

Hong X, Nelson K, Lemke N, Kalkanis SN.

Int J Oncol. 2012 Feb;40(2):494-500. doi: 10.3892/ijo.2011.1229. Epub 2011 Oct 13.

PMID:
22001963
12.

Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.

Lee SH, Kim J, Kim WH, Lee YM.

Oncogene. 2009 Jan 15;28(2):184-94. doi: 10.1038/onc.2008.377. Epub 2008 Oct 13.

PMID:
18850007
13.

Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells.

Meng CF, Zhu XJ, Peng G, Dai DQ.

Cancer Invest. 2010 May;28(4):331-9. doi: 10.3109/07357900903179633.

PMID:
19857042
14.

Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

El-Awady RA, Hersi F, Al-Tunaiji H, Saleh EM, Abdel-Wahab AH, Al Homssi A, Suhail M, El-Serafi A, Al-Tel T.

Cancer Biol Ther. 2015;16(7):1056-70. doi: 10.1080/15384047.2015.1046023.

15.

Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.

Dannenberg LO, Chen HJ, Tian H, Edenberg HJ.

Alcohol Clin Exp Res. 2006 Jun;30(6):928-37.

PMID:
16737450
16.

Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.

Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T, Zhang X, Han B, Zhou G.

J Hepatol. 2010 Nov;53(5):889-95. doi: 10.1016/j.jhep.2010.05.012. Epub 2010 Jul 14.

PMID:
20675009
17.

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.

Oncogene. 2001 Nov 22;20(53):7787-96.

18.

Epigenetic regulation of microRNA expression in colorectal cancer.

Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J.

Int J Cancer. 2009 Dec 1;125(11):2737-43. doi: 10.1002/ijc.24638.

19.

Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF.

PLoS One. 2012;7(6):e38955. doi: 10.1371/journal.pone.0038955. Epub 2012 Jun 12.

20.

Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.

Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.

Mol Carcinog. 2005 Dec;44(4):233-41.

PMID:
16163707

Supplemental Content

Support Center